Objective To investigate the role of tumor markers in the diagnosis, pathological classification, progression and therapeutic efficiency evaluation in patients with NSCLC.

• 目的探讨血清肿瘤标记物联合检测在非小细胞肺癌(NSCLC)的诊断、分型、病情估价和疗效中的作用。